<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">K G Geetha</style></author><author><style face="normal" font="default" size="100%">Mohind C Mohan</style></author><author><style face="normal" font="default" size="100%">V Manju</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Phytochemical Profile and Bioactivity of Dioscorea transversa R. Br: Antioxidant and Anti-Inflammatory Potential of Leaf and Tuber</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">COX-2</style></keyword><keyword><style  face="normal" font="default" size="100%">Dioscorea transversa</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Oxidative stress</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytochemicals</style></keyword><keyword><style  face="normal" font="default" size="100%">TNF-α</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">718-726</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Various species of &lt;em&gt;Dioscorea&lt;/em&gt;, commonly referred to as wild yams, are employed as food and used globally for medicinal purposes. &lt;em&gt;D&lt;/em&gt;i&lt;em&gt;oscorea transversa&lt;/em&gt;, also known as the long or pencil yam, is a native to northern and eastern Australia and is also found in the open forests of southern India. The tubers of this plant are consumed by local tribes in northern Kerala during times of famine, and they are believed to enhance bone and muscle strength. Furthermore, it is incorporated with other ingredients in their traditional postnatal rejuvenation preparations. However, this plant which is infrequently examined for its biochemical impacts on humans. This research aimed to identify the phytochemicals present in the tuber and leaf of &lt;em&gt;Dioscorea transversa&lt;/em&gt; and to assess solvent extracts for their antioxidant and anti-inflammatory properties. The leaf sample demonstrated a notable concentration of phenolic compounds, tannins, flavonoids, and terpenoids, while the tuber was rich in saponins, proteins, and steroids. It was noted that the aqueous methanolic extract of the leaves (AqML) exhibited superior antioxidant and anti-inflammatory activity in comparison to the other five extracts explored. This study underscores &lt;em&gt;D. transversa&lt;/em&gt; as a significant source of natural bioactive compounds and advocates for further research to delve deeper into the pharmacological potential of this plant&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">718</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;K G Geetha&lt;sup&gt;1&lt;/sup&gt;, Mohind C Mohan&lt;sup&gt;2&lt;/sup&gt;, V Manju&lt;sup&gt;1*&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Biochemistry, Periyar University, Salem, INDIA.&amp;nbsp;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biochemistry, PSG Institute of Medical Sciences and Research, Coimbatore, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Prajna R H</style></author><author><style face="normal" font="default" size="100%">Shivananda Nayak</style></author><author><style face="normal" font="default" size="100%">Priya V</style></author><author><style face="normal" font="default" size="100%">Shruthi Rai P</style></author><author><style face="normal" font="default" size="100%">Shivaraja shankara Y M</style></author><author><style face="normal" font="default" size="100%">Prashanthkumar Goudappala</style></author><author><style face="normal" font="default" size="100%">Dinesh PV</style></author><author><style face="normal" font="default" size="100%">Namratha KG</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">The role of TNF-Alpha, IL-6, Adiponectin, and Leptin in Inflammation and Metabolic Dysregulation in Type 2 Diabetes Mellitus</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Adiponectin</style></keyword><keyword><style  face="normal" font="default" size="100%">IL-6</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Leptin</style></keyword><keyword><style  face="normal" font="default" size="100%">Metabolic Dysregulation</style></keyword><keyword><style  face="normal" font="default" size="100%">TNF-Alpha</style></keyword><keyword><style  face="normal" font="default" size="100%">Type 2 diabetes mellitus</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2025</style></year><pub-dates><date><style  face="normal" font="default" size="100%">December 2025</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">17</style></volume><pages><style face="normal" font="default" size="100%">699-702</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Type 2 Diabetes Mellitus (T2DM) is characterized by chronic inflammation and metabolic dysregulation. The present study investigates the role of inflammatory markers, including TNF-alpha and IL-6, and metabolic hormones such as adiponectin and leptin, in individuals with T2DM. &lt;strong&gt;Methods:&lt;/strong&gt; A total of 147 participants diagnosed with T2DM were included in the study. Clinical and biochemical parameters, including fasting blood sugar (FBS), glycated hemoglobin (HbA1C), adiponectin, leptin, TNF-alpha, and IL-6, were measured. Descriptive statistics and correlation analysis were performed to determine associations between inflammatory markers and metabolic dysregulation.&lt;strong&gt; Results: &lt;/strong&gt;The mean age of participants was &lt;strong&gt;42.63 ± 6.38 &lt;/strong&gt;years, and the average BMI was &lt;strong&gt;28.38 ± 2.25 kg/m²&lt;/strong&gt;. FBS and HbA1C levels were &lt;strong&gt;175.72 ± 61.61 mg/dL&lt;/strong&gt; and &lt;strong&gt;7.26 ± 0.94%,&lt;/strong&gt; respectively. The mean adiponectin and leptin levels were &lt;strong&gt;4.71 ± 1.75 μg/mL&lt;/strong&gt; and &lt;strong&gt;20.58 ± 5.19 ng/mL&lt;/strong&gt;, respectively. TNF-alpha and IL-6 levels averaged &lt;strong&gt;132.00 ± 9.45 pg/mL&lt;/strong&gt; and &lt;strong&gt;33.52 ± 14.55 pg/mL&lt;/strong&gt;, respectively. Correlation analysis indicated an inverse relationship between adiponectin and BMI, while leptin was positively correlated with BMI and insulin levels. Elevated TNFalpha and IL-6 levels were associated with increased HbA1C and fasting blood glucose. &lt;strong&gt;Conclusion: &lt;/strong&gt;This study highlights the significant role of inflammatory markers in metabolic dysregulation among T2DM patients. Elevated TNF-alpha and IL-6 levels reinforce the link between chronic inflammation and impaired glucose metabolism. These findings underscore the need for anti-inflammatory strategies in diabetes management.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">6</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">699</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Prajna R H&lt;sup&gt;1,2&lt;/sup&gt;, Shivananda Nayak&lt;sup&gt;3&lt;/sup&gt;, Priya V&lt;sup&gt;4*&lt;/sup&gt;, Shruthi Rai P&lt;sup&gt;5&lt;/sup&gt;, Shivaraja shankara Y M&lt;sup&gt;6&lt;/sup&gt;, Prashanthkumar Goudappala&lt;sup&gt;7&lt;/sup&gt;, Dinesh PV&lt;sup&gt;8&lt;/sup&gt;, Namratha KG&lt;sup&gt;9&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Research scholar, SaveethaResearch Center, Saveetha Institute of Medical and Technical Sciences(SIMATS), Chennai, INDIA,600077&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Assistant Professor, Department of Biochemistry, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Professor, Department of Biochemistry, Subbaiah Institute of Medical Science, Shivamogga, INDIA,577222&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Professor, Center of Molecular Medicine and Diagnostics (COMManD), Department of Biochemistry, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences, Saveetha University Chennai, INDIA,600077&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;5&lt;/sup&gt;Professor, Department of Biochemistry, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;6&lt;/sup&gt;Professor, Department of Biochemistry, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;7&lt;/sup&gt;Associate Professor, Department of Biochemistry, Sri Siddhartha Medical College, Sri Siddhartha Academy of Higher Education, Tumkur, INDIA ,572107&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;8&lt;/sup&gt;Professor, Department of Community medicine, KVG Medical College and Hospital, Sullia, INDIA, 574327&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;9&lt;/sup&gt;Professor, Department of Microbiology, KVG Medical College and Hospital,Sullia , INDIA, 574327.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rena Normasari</style></author><author><style face="normal" font="default" size="100%">Bambang Purwanto</style></author><author><style face="normal" font="default" size="100%">Damayanti Tinduh</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Protective Effects of Rutinoside on Oxidative Induced Articular Cartilage Damage and Catabolic Activity in Rat Chondrocyte</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Osteoarthritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Oxidative stress</style></keyword><keyword><style  face="normal" font="default" size="100%">Rutinoside</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2024</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2024</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">16</style></volume><pages><style face="normal" font="default" size="100%">360-365</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Objective:&lt;/strong&gt; This study aimed to look into the therapeutic potential of rutinoside in reducing articular cartilage degeneration in a rat model of osteoarthritis generated by monosodium iodoacetate (MIA). &lt;strong&gt;Methods:&lt;/strong&gt; We formed three groups of male Wistar rats: the OA, rutinoside, and control groups. Monosodium iodoacetate (3.0 mg) was injected intra-articularly into the knee joint to cause osteoarthritis. For four weeks, oral administration of rutinoside at 100 mg/kg/day was given to the groups that were given the treatment. Histological examination, immunohistochemistry, and biochemical tests were used to assess the level of articular cartilage injury, oxidative damage, catabolic activity, and biomarker expression. &lt;strong&gt;Results:&lt;/strong&gt; The results showed that treatments with rutinoside significantly reduced the damage to articular cartilage in rats with MIA-induced osteoarthritis. Compared to the osteoarthritis group, the rutinoside-treated groups showed enhanced cartilage structure, proteoglycan content, and chondrocyte organization. Immunohistochemistry revealed reduced NFκB, IL-1β, and MMP-13 expressions in the rutinosidetreated groups, indicating suppressed inflammatory and catabolic activity in chondrocytes. Additionally, rutinoside treatment increased SOD activity and decreased MDA levels, which showed less oxidative damage to the joint. A substantial drop in CTX-II levels was found by biochemical research, indicating less type II collagen breakdown. &lt;strong&gt;Conclusion: &lt;/strong&gt;According to a study, rutinoside effectively reduces oxidative damage and catabolic activity in chondrocytes, which can lead to decreased articular cartilage loss in a rat model of MIA-induced osteoarthritis. The study also found that rutinoside can control critical biomarkers such as NFκB, IL-1β, SOD, MDA, MMP-13, and CTX-II, highlighting its potential as a treatment for osteoarthritis. These findings provide valuable insights into using natural chemicals as a promising treatment for OA and suggest that rutinoside could potentially modulate the critical interplay between oxidative stress, inflammation, and chondrocyte catabolism in osteoarthritis. However, further research is required to understand the underlying molecular mechanisms and evaluate rutinoside's translational potential for OA therapy.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">360</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p&gt;&lt;strong&gt;Rena Normasari&lt;sup&gt;1,2&lt;/sup&gt;, Bambang Purwanto&lt;sup&gt;3*&lt;/sup&gt;, Damayanti Tinduh&lt;sup&gt;4&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;1&lt;/sup&gt;Doctoral Program, Faculty of Medicine, Airlangga University, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;2&lt;/sup&gt;Pathology Anatomy Department, Medical Faculty, Jember University, INDONESIA.&lt;/p&gt;

&lt;p&gt;&lt;sup&gt;3&lt;/sup&gt;Physiology Department, Faculty of Medicine, Airlangga University, INDONESIA. 4Physical Medicine and Rehabilitation Department, Faculty of Medicine, Airlangga University, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Tarkeshwar Dubey</style></author><author><style face="normal" font="default" size="100%">Kancharla Bhanukiran</style></author><author><style face="normal" font="default" size="100%">Kuna Das</style></author><author><style face="normal" font="default" size="100%">Siva Hemalatha</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Development and Evaluation of Bio fabricated Silver Nanoparticles from Blumea lacera for In-vitro Antibacterial, Antioxidant and Anti-inflammatory Activity</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Green synthesis</style></keyword><keyword><style  face="normal" font="default" size="100%">HPTLC.</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Kukrounda</style></keyword><keyword><style  face="normal" font="default" size="100%">Phytopharmaceuticals</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">April 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">266-278</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Increasing prevalence of microbial resistance and side effects of currently available drugs compels the researchers to look for alternate therapies and formulations to overcome this problem. Plant based formulations have been proved to be most reliable agents in recent times. &lt;strong&gt;Objective: &lt;/strong&gt;In the current study, bio fabricated herbal silver nanoparticles (HSNPs) were prepared by reducing silver nitrate (AgNO&lt;sub&gt;3&lt;/sub&gt;) solution with ethyl acetate fractions (EAF) of &lt;em&gt;Blumea lacera &lt;/em&gt;extracts. These bios conjugated HSNPs were then assessed for potential anti-inflammatory and antibacterial activities along with&lt;em&gt; in vitro&lt;/em&gt; antioxidant effect. &lt;strong&gt;Methods and Results: &lt;/strong&gt;The synthesis was confirmed by absorbance peak at 441 nm due to surface plasmon resonance in UV-visible spectrophotometer. FTIR spectra of HSNPs indicated the phytochemicals having C-O bond responsible for reducing of Ag&lt;sup&gt;+&lt;/sup&gt; to Ag&lt;sup&gt;o&lt;/sup&gt;. Average size of HSNPs was found to be 59.21 nm which was in good agreement with TEM and SEM results. EDS analysis showed the existence of Silver, Nitrogen and Carbon in HSNPs. The antibacterial activity of HSNPs in terms of zone of inhibition (ZOI) &lt;em&gt;via&lt;/em&gt; disc diffusion assay and against &lt;em&gt;Staphylococcus aureus&lt;/em&gt; and &lt;em&gt;Escherichia coli &lt;/em&gt;was found to be 25.0±1.19 mm and 18.3±2.08 mm, respectively. The minimum inhibitory concentration (MIC) of HSNPs was found to be 50 μg/ml and 60 μg/ml against S. aureus and E. coli, respectively. The antioxidant capacity of the HSNPs was insignificant as compared to EAF but the results of anti-inflammatory activity was significant (p&amp;lt;0.05).&lt;strong&gt; Conclusion:&lt;/strong&gt; The overall result demonstrated better &lt;em&gt;in-vitro&lt;/em&gt; pharmacological potential of HSNPs compared to neat extract/EAF. Key words: Green synthesis, Phytopharmaceuticals, Inflammation, Kukrounda, HPTLC.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article </style></work-type><section><style face="normal" font="default" size="100%">266</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Tarkeshwar Dubey&lt;sup&gt;1&lt;/sup&gt;, Kancharla Bhanukiran&lt;sup&gt;1&lt;/sup&gt;, Kuna Das&lt;sup&gt;2&lt;/sup&gt;, Siva Hemalatha&lt;sup&gt;1,*&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmaceutical Engineering &amp;amp; Technology, Indian Institute of Technology, Banaras Hindu University, Varanasi-221005, INDIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Biotechnology and Medical Engineering, National Institute of Technology, Rourkela, Odisha-769008, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sumarawati T</style></author><author><style face="normal" font="default" size="100%">Chodidjah</style></author><author><style face="normal" font="default" size="100%">Dina Fatmawati</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Effect of Combination of Soybean and Phaleria macrocarpa Ethanol Extract on IL6, TNFα, VEGF and Fibroblasts in Mice Exposed to UVB</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Skin wound</style></keyword><keyword><style  face="normal" font="default" size="100%">UV B radiation</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">6-13</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;UV exposure causes inflammation and the generation of reactive oxygen species, both of which contribute to skin aging. The purpose of this research was to determine how a combination of &lt;em&gt;Phaleria macrocarpa &lt;/em&gt;extract and soybean extract affected the number of fibroblasts, VEGF, IL-6, and TNF alpha expression, and blood levels of IL-6 and TNF alpha in UV-B-exposed mice. In this study, mice were placed into four groups: one control group, three treatment groups, and a combination of &lt;em&gt;Phaleria macrocarpa&lt;/em&gt;:soybeans at a 1:1 ratio (com group). The mice were euthanized on days 5 and 21 for histological preparations and then examined under a light microscope. Using an Olympus C-21 microscope with an Optilab Advances camera at 1000x magnification, the fibroblast was studied by counting the number of fibroblast cells per field of view. The immunohistochemical approach was performed to analyze the expression of VEGF, IL-6, and TNF- in skin tissue. The ELISA technique was used to quantify the levels of IL-6 and TNF-alpha. SPSS ver 21 was used to analyze the data. On days 5 and 21, the number of fibroblasts and expression of VEGF, IL-6, and TNF alpha were significantly higher in the combination group than in the control, &lt;em&gt;Phaleria macrocarpa&lt;/em&gt;, and soybean treatment groups. However, there was no significant change in IL-6 and TNF alpha levels across groups on days 5 and 21 (p &amp;gt; 0.05). Finally, a 1:1 mixture of &lt;em&gt;Phaleria macrocarpa&lt;/em&gt; and soybeans reduced the number of fibroblasts and the production of VEGF, IL-6, and TNF alpha on days 5 and 21, but not in serum levels.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">6</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Sumarawati T&lt;sup&gt;1,*&lt;/sup&gt;, Chodidjah&lt;sup&gt;2&lt;/sup&gt;, Dina Fatmawati&lt;sup&gt;3&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Chemistry, Faculty of Medicine, Universitas Islam Sultan Agung, INDONESIA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Anatomi, Faculty of Medicine, Universitas Islam Sultan Agung&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Biology, Faculty of Medicine, Universitas Islam Sultan Agung, INDONESIA&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Omar M. Alsaffar</style></author><author><style face="normal" font="default" size="100%">Maha T. Al-Saffar</style></author><author><style face="normal" font="default" size="100%">Abdulsattar S. Mahmood</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Lisinopril-Induced CD34 Bone Healing Marker</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Bone healing</style></keyword><keyword><style  face="normal" font="default" size="100%">Bone injury</style></keyword><keyword><style  face="normal" font="default" size="100%">CD34.</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Lisinopril</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2023</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2023</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">15</style></volume><pages><style face="normal" font="default" size="100%">208-211</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Background: &lt;/strong&gt;Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor that is commonly used to treat high blood pressure and heart failure. While it is generally well-tolerated, some studies have suggested that it may affect bone healing, suggesting that lisinopril treatment was associated with an increase in the CD34 bone healing marker in patients with tibial fractures. CD34 is a protein that is involved in the formation of new blood vessels and has been shown to play a role in bone healing. &lt;strong&gt;Methods: &lt;/strong&gt;The study used 24 rabbits with artificially induced tibial bone fracture divided into 4 groups (6 rabbits each), the control group treated with distilled water and 3 groups treated with lisinopril. Each group were sacrificed for immunohistochemical study on 3 timepoints at day 7, 14, and 21. &lt;strong&gt;Results: &lt;/strong&gt;Indicated that the lisinopril group had significantly higher levels of CD34 than the control group. &lt;strong&gt;Conclusion:&lt;/strong&gt; While the results of this study suggest that lisinopril may have a positive effect on bone healing, more research is needed to confirm these findings and to determine the mechanisms by which lisinopril may affect bone healing. It is also important to note that lisinopril may have other potential side effects, and patients should discuss any concerns with their healthcare provider&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Research Article</style></work-type><section><style face="normal" font="default" size="100%">208</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Omar M. Alsaffar*, Maha T. Al- Saffar, Abdulsattar S. Mahmood&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;College of Dentistry, University of Mosul, Mosul, IRAQ.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Kusmardi Kusmardi</style></author><author><style face="normal" font="default" size="100%">Elvan Wiyarta</style></author><author><style face="normal" font="default" size="100%">Ari Estuningtyas</style></author><author><style face="normal" font="default" size="100%">Nurhuda Sahar</style></author><author><style face="normal" font="default" size="100%">Yurnadi Hanafi Midoen</style></author><author><style face="normal" font="default" size="100%">Aryo Tedjo</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Potential of Phaleria macrocarpa Leaves Ethanol Extract to Upregulate the Expression of Caspase-3 in Mouse Distal Colon after Dextran Sodium Sulphate Induction</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Apoptosis</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Mahkota Dewa</style></keyword><keyword><style  face="normal" font="default" size="100%">Ulcerative colitis</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2021</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2021</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">13</style></volume><pages><style face="normal" font="default" size="100%">23-29</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;Ulcerative colitis (UC) is a part of incurable chronic inflammatory disease that has gained importance over the past few decades. A lot of research has been done to find effective treatments for UC, one of which is herbal medicine. &lt;em&gt;Phaleria macrocarpa&lt;/em&gt; (PM), an Indonesian native plant, is thought to be an alternative therapy for UC because of its anti-inflammatory properties. Therefore, in this research, &lt;em&gt;Phaleria macrocarpa&lt;/em&gt; Leaves Ethanol Extract (&lt;em&gt;PM&lt;/em&gt;LEE) is used to assess its effect on UC by using Caspase-3 as apoptosis marker. PMLEE was made from dried material of PM that undergo maceration. Animals were separated into six groups: normal, negative control, positive control, and PMLEE groups (100, 200, 300 mg/kgBW). PMLEE was then injected to BALB/c mice that have been induced by dextran sodium sulphate (DSS) for 7 consecutive days. DSS is used to model UC in mice colon tissue. All animals were sacrificed and their colons were collected then stained with anti-Caspase-3. The stained sections were subsequently examined with ImageJ based on color intensity which generated H-Score as the results. Based on H-Score of each group, PMLEE 300mg has significantly upregulate the expression of Caspase-3 compare to the negative control (p=0.015). PMLEE also has a tendency to be dose dependent based on the significant difference between PMLEE doses. Therefore, it concludes that PMLEE is able to upregulate the expression of Caspase-3 in colon cells as in this study it was directly proportional. &lt;strong&gt;Key words:&lt;/strong&gt; Mahkota Dewa, Inflammation, Apoptosis, Ulcerative colitis.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">23</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Kusmardi Kusmardi&lt;sup&gt;1&lt;/sup&gt;, Elvan Wiyarta&lt;sup&gt;2,&lt;/sup&gt;*, Ari Estuningtyas&lt;sup&gt;3&lt;/sup&gt;, Nurhuda Sahar&lt;sup&gt;4&lt;/sup&gt;, Yurnadi Hanafi Midoen&lt;sup&gt;4&lt;/sup&gt;, Aryo Tedjo&lt;sup&gt;5 &lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Anatomic Pathology, Drug Development Research Cluster, Human Cancer Research Center, IMERI, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya 6 Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya 6 Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmacology and Therapeutic, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya 6 Jakarta, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;4&lt;/sup&gt;Department of Medical Biology, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya 6 Jakarta, INDONESIA&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;5Department Medical Chemistry, Faculty of Medicine, Universitas Indonesia, Jl. Salemba Raya 6 Jakarta, INDONESIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Didin Wahyu Agustina</style></author><author><style face="normal" font="default" size="100%">Mulya Dwi Wahyuningsih</style></author><author><style face="normal" font="default" size="100%">Sri Widyarti</style></author><author><style face="normal" font="default" size="100%">Aris Soewondo</style></author><author><style face="normal" font="default" size="100%">Hideo Tsuboi</style></author><author><style face="normal" font="default" size="100%">Muhaimin Rifa’i</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Noni Juice (Morinda citrifolia) to Prevent Cancer Progression in Mice Induced DMBA and Cigarette Smoke Exposure</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Homeostatic</style></keyword><keyword><style  face="normal" font="default" size="100%">Immunotoxin</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Noni juice</style></keyword><keyword><style  face="normal" font="default" size="100%">Tumor progression</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2020</style></year><pub-dates><date><style  face="normal" font="default" size="100%">August 2020</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">12</style></volume><pages><style face="normal" font="default" size="100%">946-951</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Introduction: &lt;/strong&gt;Accumulation of polycyclic aromatic hydrocarbons (PAH) in the body commonly lead to degenerative disease such as cancer. This study aims to investigate the potential of &lt;em&gt;Morinda citrifolia&lt;/em&gt; to maintain the immune system against toxic exposure. &lt;strong&gt;Materials and Methods: &lt;/strong&gt;This study used Five weeks old male Balb/C mice as animal model. The 7,12-Dimethylbenz(a)anthracene (DMBA) was administrated for six weeks following with 3 days cigarette smoke (CS) exposure then treated with noni juice (&lt;em&gt;M. citrifolia&lt;/em&gt;) for two weeks. Experimental animals were divided into six groups. Normal control (N); DMBA+CS; Cisplatin; D1; D2; and D3. Profil of CD4&lt;sup&gt;+&lt;/sup&gt;TNFα&lt;sup&gt;+&lt;/sup&gt;, CD11b+IL6&lt;sup&gt;+&lt;/sup&gt;, CD11b&lt;sup&gt;+&lt;/sup&gt;IFNγ&lt;sup&gt;+&lt;/sup&gt;, CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt; IL10&lt;sup&gt;+&lt;/sup&gt;, NK&lt;sup&gt;+&lt;/sup&gt;IL6&lt;sup&gt;+&lt;/sup&gt; cells was analyzed by flow cytometry and data was analyzed with one-way ANOVA and Post Hoc Tukey HSD test with a significance of p-values &amp;lt; 0.05. &lt;strong&gt;Results:&lt;/strong&gt; This study show that DMBA+CS induction increasing level of CD11b&lt;sup&gt;+&lt;/sup&gt;IL6&lt;sup&gt;+&lt;/sup&gt;, CD4&lt;sup&gt;+&lt;/sup&gt;CD25&lt;sup&gt;+&lt;/sup&gt; IL-10&lt;sup&gt;+&lt;/sup&gt; and NK&lt;sup&gt;+&lt;/sup&gt; IL-6&lt;sup&gt;+&lt;/sup&gt; meanwhile decreasing CD4&lt;sup&gt;+&lt;/sup&gt;TNFα&lt;sup&gt;+&lt;/sup&gt;significantly (P&amp;lt;0.5) than Normal group. Noni juice in dose 90 mg/Kg BW decrease cytokine pro-inflammation (IL-6 and IFNγ) both in macrophage and NK cell profile significantly (P&amp;lt;0.05). Noni juice in 30 mg/Kg BW could improve the activation CD4&lt;sup&gt;+&lt;/sup&gt;TNFα&lt;sup&gt;+&lt;/sup&gt; significantly (P&amp;lt;0.05). Noni juice also has efficacy to control T regulator activation to prevent tumor escape. &lt;strong&gt;Conclusion: &lt;/strong&gt;These results suggest that noni juice has anti-cancer potencies by maintain homeostasis of immune system and could be immune herbal supplement.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">5</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">946</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p class=&quot;rtejustify&quot;&gt;&lt;strong&gt;Didin Wahyu Agustina&lt;sup&gt;1&lt;/sup&gt;, Mulya Dwi Wahyuningsih&lt;sup&gt;1&lt;/sup&gt;, Sri Widyarti&lt;sup&gt;1&lt;/sup&gt;, Aris Soewondo&lt;sup&gt;1&lt;/sup&gt;, Hideo Tsuboi&lt;sup&gt;3&lt;/sup&gt;, Muhaimin Rifa’i&lt;sup&gt;1,2&lt;/sup&gt;,* &lt;/strong&gt;&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Biology Department, Faculty of Mathematics and Natural sciences, Brawijaya University. Malang 65145, East Java, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Biosystems Research Center, LPPM University of Brawijaya, Malang 65145, East Java, INDONESIA.&lt;/p&gt;

&lt;p class=&quot;rtejustify&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Immunology, Nagoya University Graduate School of Medicine, 65 Tsurumai-cho, Showa-ku, Nagoya 466-8550, JAPAN.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Melakhessou Mohamed Akram</style></author><author><style face="normal" font="default" size="100%">Benkiki Naima</style></author><author><style face="normal" font="default" size="100%">Marref Salah Eddine</style></author><author><style face="normal" font="default" size="100%">Bouzidi Soumia</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-Inflammatory, Anti-pyretic and Acute Toxicity Effects of n-Butanol Extract of Atractylis flava Desf in Rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Atractylis flava desf</style></keyword><keyword><style  face="normal" font="default" size="100%">Brewer’s yeast</style></keyword><keyword><style  face="normal" font="default" size="100%">Egg albumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Pyrexia</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/666</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">763-767</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Objectives:&lt;/strong&gt; This study was aimed to explore the antipyretic and anti-inflammatory effects of &lt;em&gt;n&lt;/em&gt;-butanol etract of &lt;em&gt;Atractylis flava &lt;/em&gt;Desf &lt;em&gt;(A. Flava)&lt;/em&gt; using experimentally induced inflammation and pyrexia models in rats. &lt;strong&gt;Methods:&lt;/strong&gt; In the acute toxicity study, a single oral dose of 2000 mg/kg of&lt;em&gt; n&lt;/em&gt;-butanol extract was given to rats. The antipyretic activity was evaluated using brewer&amp;rsquo;s yeast induced pyrexia in rats. In addition, albumin induced rat paw edema was performed by the injection of 100 &amp;mu;L undiluted fresh egg albumin to assess the anti-inflammatory effects of the plant. &lt;strong&gt;Results:&lt;/strong&gt; The results of the present study revealed that&lt;em&gt; n&lt;/em&gt;-butanol extract of &lt;em&gt;A. Flava&lt;/em&gt; significantly (&lt;em&gt;P&lt;/em&gt;&amp;lt;0.001) reduced fresh egg albumin-induced rat paw edema and also inhibited fever significantly in brewer&amp;rsquo;s yeast induced pyrexia. &lt;strong&gt;Conclusion:&lt;/strong&gt; The results of the present study indicated that &lt;em&gt;A. flava&lt;/em&gt; possesses antipyretic and anti-inflammatory activity in the models studied.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">763</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Melakhessou Mohamed Akram*, Benkiki Naima, Marref Salah Eddine, Bouzidi Soumia &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Laboratoire de Biotechnologie des Mol&amp;eacute;cules Bioactives et de la Physiopathologie Cellulaire. Universit&amp;eacute; de Batna-2, 05000, ALGERIE.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Debasish Pradhan</style></author><author><style face="normal" font="default" size="100%">Toffa Dasmohapatra</style></author><author><style face="normal" font="default" size="100%">Gitanjali Tripathy</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Pharmacognostic Evaluation of Curcumin on Diabetic Retinopathy in Alloxan-induced Diabetes through NF-KB and Brn3a Related Mechanism</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Brn3a</style></keyword><keyword><style  face="normal" font="default" size="100%">CaKMII</style></keyword><keyword><style  face="normal" font="default" size="100%">Curcumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">NF-KB</style></keyword><keyword><style  face="normal" font="default" size="100%">Oxidative stress</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">January 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/486</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">324-332</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Background:&lt;/strong&gt; Diabetic retinopathy is one of the most common micro vascular complication of diabetes and involves an abnormal pathology of major retinal pigment epithelium, inter retinal oedema and intraocular neovascularisation where pro-inflammatory proteins including ICAM-1,iNOS and VEGF release by activation of enzyme CaMKII/NF-kB expression Diabetic induced oxidative stress followed by deactivation of Brn3a expression in the retinal ganglionic cells are also early events in pathogenesis of Diabetic retinopathy. These factors are important contributors to the development of clinically significant diabetic retinopathy. &lt;strong&gt;Objective:&lt;/strong&gt; Objective of this study to examine the effect of curcumin with antioxidant and anti-inflammatory properties obtained from &lt;em&gt;Curcuma longa&lt;/em&gt; against diabetes-induced retinal vascular damage and its mechanism of action by &lt;em&gt;in-vivo&lt;/em&gt; in retinas of rat rendered diabetic by alloxan and &lt;em&gt;in vitro&lt;/em&gt; in western blotting and RGC tissue culture. &lt;strong&gt;Method:&lt;/strong&gt; We administered curcumin or saline vehicle to experimental animals daily for 12 weeks. Vascular permeability, expression of CaMK II/NF-kB, Retinal morphology and neuropathic change of the retinal ganglion cells were investigated. &lt;strong&gt;Results:&lt;/strong&gt; As an anti-oxidant, curcumin raised Retinal Ganglionic cells by increasing Brn3a expression during oxidative stress condition and subsequently decreased the expression of inflammatory mediators such as VEGF, iNOS and ICAM-1 as an anti-inflammatory agent by inhibiting CaMKII and NF-kB expression. &lt;strong&gt;Conclusion:&lt;/strong&gt; Curcumin, a common food additive has beneficial effects in experimental studies of diseases that are characterised by increased oxidative stress and inflammatory reactions. It appears to be a useful adjunct therapy to possibly inhibit the progression of retinopathy, sight threatening complication faced by diabetic patients.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">324</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Debasish Pradhan&lt;sup&gt;1*&lt;/sup&gt;, Toffa Dasmohapatra&lt;sup&gt;2&lt;/sup&gt;, Gitanjali Tripathy&lt;sup&gt;3&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmaceutical Sciences,Creighton University, Carlifornia Plaza,Omaha,NE68102, USA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmaceutical Sciences,Utkal University, Odisha, INDIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department Of Pharmacy, Government Polytechnic, Chandrashekharpur, Odisha, INDIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Niken Indriyanti</style></author><author><style face="normal" font="default" size="100%">Afrillia Nuryanti Garmana</style></author><author><style face="normal" font="default" size="100%">Finna Setiawan</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Repairing Effects of Aqueous Extract of Kalanchoe pinnata (Lmk) Pers. on Lupus Nephritis Mice</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Docking</style></keyword><keyword><style  face="normal" font="default" size="100%">Glomerulonephritis</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Lupus</style></keyword><keyword><style  face="normal" font="default" size="100%">Proteinuria</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2018</style></year><pub-dates><date><style  face="normal" font="default" size="100%">March 2018</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://fulltxt.org/article/522</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">10</style></volume><pages><style face="normal" font="default" size="100%">548-552</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;em&gt;Kalanchoe pinnata&lt;/em&gt; (Lmk) Pers (KP) has an immunosuppressive effect on delayed-type hypersensitivity test. Based on it, this research aimed to determine the repairing effects of aqueous extract of KP on lupus nephritis mice and identified its active compound. The KP extract profile was determined using UPLC-QTOF-MS/MS instrument. We examined six mice groups consisting of three curative treatment groups, one standard group receiving prednisone, one preventive group receiving KP extract, and one healthy (healthy and untreated) group. At the end of the experiment, we measured the proteinuria and renal histology parameters. To recognize the active compound in the KP profile, we performed &lt;em&gt;in silico&lt;/em&gt; assays for the flavonoid compounds to bind to the glucocorticoid receptor. We played &lt;em&gt;in silico&lt;/em&gt; tests for the flavonoid compounds to identify the active compound in the KP profile. We found the repairing effect of KP was detected in the kidney, demonstrated by its low proteinuria level and its better tissue structure. In the curative group, the urine protein level and its glomerular inflammation decreased. In the preventive group, the aqueous extract of KP could prevent lupus nephritis manifestations in the kidney. Bryophyllin A is the most active compound of the KP. However, further research is needed to understand the mechanism involved. We conclude, the aqueous extract, especially its bryophyllin A, have beneficial effects in repairing the function and tissue structure of lupus manifestations in mice kidney.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">548</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Niken Indriyanti&lt;sup&gt;1*&lt;/sup&gt;, Afrillia Nuryanti Garmana&lt;sup&gt;2&lt;/sup&gt;, Finna Setiawan&lt;sup&gt;3&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Faculty of Pharmacy, Mulawarman University, East Kalimantan, INDONESIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology and Clinical Pharmacy, School of Pharmacy, Bandung Institute of Technology, West Java, INDONESIA.&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Department of Pharmaceutical Biology, Faculty of Pharmacy, Universitas Surabaya, East Java, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Amanda Listiyani</style></author><author><style face="normal" font="default" size="100%">Berna Elya</style></author><author><style face="normal" font="default" size="100%">Nuraini Puspitasari</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Antioxidant Activity and Lipoxygenase Enzyme Inhibitory Assay with Total Flavonoids Content from Garcinia hombroniana Pierre Stem Bark Extract</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Antioxidant</style></keyword><keyword><style  face="normal" font="default" size="100%">Garcinia hombroniana Pierre</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Lipoxygenase</style></keyword><keyword><style  face="normal" font="default" size="100%">Total flavonoids content</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2017</style></year><pub-dates><date><style  face="normal" font="default" size="100%">February 2017</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">http://phcogj.com/fulltext/314</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">9</style></volume><pages><style face="normal" font="default" size="100%">276-279</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; &lt;em&gt;Garcinia&lt;/em&gt; has been known as a rich source of xanthones, flavonoids, and phenols. The aim of this research is to obtain data of antioxidant activity and to observe potential inhibition of lipoxygenase activity that most active from methanolic, ethyl acetate and n-hexane extracts with total flavonoids content from most active extracts from the bark of &lt;em&gt;Garcinia&lt;/em&gt; &lt;em&gt;hombroniana&lt;/em&gt; Pierre. &lt;strong&gt;Methods:&lt;/strong&gt; The antioxidant activity was measured using the ferric reducing antioxidant power (FRAP), the anti-inflammatory assay was measured using inhibition of lipoxygenase activity test, qualitative analysis of flavonoids using thin layer chromatography, and total flavonoids content was measured using AlCl&lt;sub&gt;3&lt;/sub&gt; colorimetric method. &lt;strong&gt;Results:&lt;/strong&gt; The results showed that the ethyl acetate extract from &lt;em&gt;G. hombroniana&lt;/em&gt; Pierre stem bark as the most active extract for antioxidant and lipoxygenase inhibition activity with EC&lt;sub&gt;50&lt;/sub&gt; and IC&lt;sub&gt;50&lt;/sub&gt; value consecutively 15.34 &amp;mu;g /ml; 0.26 &amp;mu;g /ml. Total flavonoids content of ethyl acetate is 7.430 mg QE/g extract. The results of this study showed bark extract &lt;em&gt;Garcinia&lt;/em&gt; &lt;em&gt;hombroniana&lt;/em&gt; Pierre has antioxidant activity and potent to inhibit lipoxygenase activity. &lt;strong&gt;Conclusion:&lt;/strong&gt; Based on the research for methanolic, ethyl acetate and n-hexane extract, it can be concluded that the ethyl acetate extract of &lt;em&gt;G. hombroniana&lt;/em&gt; Pierre as the most active extract for antioxidant and lipoxygenase inhibition activity.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">2</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">276</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Amanda Listiyani, Berna Elya*, Nuraini Puspitasari &lt;/strong&gt;&lt;/p&gt;
&lt;p style=&quot;text-align: justify;&quot;&gt;Department of Pharmacognosy- Phytochemistry, Faculty of Pharmacy, Universitas Indonesia, Kampus Baru UI Depok, 16424, Depok, INDONESIA.&lt;/p&gt;</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Sayeli Vinaykumar</style></author><author><style face="normal" font="default" size="100%">Urval Pundarik Rathnakar</style></author><author><style face="normal" font="default" size="100%">Ullal Sheetal Dinkar</style></author><author><style face="normal" font="default" size="100%">Kamath Priyanka</style></author><author><style face="normal" font="default" size="100%">Tiwary Gaurav</style></author><author><style face="normal" font="default" size="100%">Shenoy Ashok Kudgi</style></author><author><style face="normal" font="default" size="100%">Revappala Sekhar Nishith</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Anti-inflammatory activity of BCM-95 (bio-enhanced formulation of turmeric with increased bioavailabilty) compared to Curcumin in Wistar rats</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Anti-Inflammatory agents</style></keyword><keyword><style  face="normal" font="default" size="100%">Bioavailability</style></keyword><keyword><style  face="normal" font="default" size="100%">Curcumin</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Wistar rats.</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June/2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">380-384</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align:justify&quot;&gt;&lt;strong&gt;Objective&lt;/strong&gt;: To evaluate anti-inflammatory activity of bioenhanced turmeric formulation (BCM-95) compared to commercial Curcumin formulation (Curcuminoids 95%) in Carrageenan-induced acute inflammatory model. &lt;strong&gt;Materials and Methods&lt;/strong&gt;: Thirty six Wistar rats were divided into six groups-Normal control (2 ml of vehicle), Standard control (Indomethacin 10 mg/kg), 2 doses of BCM 95 (10 and 20 mg/kg) and Curcuminoids 95% (10 and 20 mg/kg). Paw volume was measured using a digital plethysmometer. Vehicle or test drugs were given to rats 30 min before carrageenan administration. Baseline paw volume reading (V&lt;sub&gt;0&lt;/sub&gt;) was noted just prior to administration of 0.1 ml of 1% carrageenan to right hind paw of the rat. Test paw volume readings (V&lt;sub&gt;t&lt;/sub&gt;) were measured at 30, 60, 120, 180, 240, 300 and 360 min, after carrageenan injection. Oedema expressed as increased paw volume (v&lt;sub&gt;t&lt;/sub&gt;-v&lt;sub&gt;0&lt;/sub&gt;) was noted and percentage inhibition of oedema was calculated for all treatment groups. &lt;strong&gt;Statistical analysis&lt;/strong&gt;: Difference between groups were analyzed with ANOVA followed by Tukey test. &lt;strong&gt;Results:&lt;/strong&gt; All treatment groups demonstrated significant (p&amp;lt;0.05) anti-inflammatory activity (oedema suppression) compared to normal control&lt;strong&gt;. &lt;/strong&gt;Anti-inflammatory activity of BCM 95 treated groups were comparable to standard control group except at certain time points, whereas the same activity at all-time points with Curcuminoid 95% treated groups were significantly less than standard control group. Percentage inhibition of paw oedema was maximum with standard control group followed by BCM 95 treated groups followed by Curcuminoid 95% treated groups. &lt;strong&gt;Conclusion:&lt;/strong&gt; BCM 95 treated groups showed significant anti-inflammatory activity compared to Curcuminoid 95% treated groups.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">380</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Sayeli Vinaykumar&lt;sup&gt;1&lt;/sup&gt;, Urval Pundarik Rathnakar&lt;sup&gt;2&lt;/sup&gt;, Ullal Sheetal Dinkar&lt;sup&gt;1&lt;/sup&gt;*, Kamath Priyanka&lt;sup&gt;1&lt;/sup&gt;, Tiwary Gaurav&lt;sup&gt;1&lt;/sup&gt;, Ashok Shenoy Kudgi&lt;sup&gt;1&lt;/sup&gt;, Revappala Sekhar Nishith&lt;sup&gt;3&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Department of Pharmacology, Kasturba Medical College, Mangaluru, Manipal University, Manipal, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Department of Pharmacology, Kanachur Institute of Medical Sciences, Deralakatte, Mangaluru. 575018, INDIA.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;3&lt;/sup&gt;Scoop Med Inc, Bengaluru, INDIA.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Zambrano-Huailla Alexander</style></author><author><style face="normal" font="default" size="100%">Zambrano-Huailla Rommel</style></author><author><style face="normal" font="default" size="100%">Goicochea-Lugo Sergio</style></author><author><style face="normal" font="default" size="100%">Zavala-Flores Ernesto</style></author><author><style face="normal" font="default" size="100%">García-Berrocal Jorge</style></author><author><style face="normal" font="default" size="100%">Chau-Saravia Angel</style></author><author><style face="normal" font="default" size="100%">Pante-Medina Carlos</style></author><author><style face="normal" font="default" size="100%">Salazar-Granara Alberto</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Study on Inflammation and the Nervous system of Ethanol extract of Jatropha Curcas seed</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Carrageenan</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Jatropha curcas</style></keyword><keyword><style  face="normal" font="default" size="100%">Nervous System.</style></keyword><keyword><style  face="normal" font="default" size="100%">Seeds</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2016</style></year><pub-dates><date><style  face="normal" font="default" size="100%">June/2016</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">8</style></volume><pages><style face="normal" font="default" size="100%">335-340</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Introduction:&lt;/strong&gt; &lt;em&gt;Jatropha curcas&lt;/em&gt; L. seeds are used in traditional medicine to treat a variety of diseases or conditions. The aim of this study is to evaluate effects on inflammation and the nervous system of ethanol extract of &lt;em&gt;J. curcas&lt;/em&gt; seeds. &lt;strong&gt;Materials and methods:&lt;/strong&gt; It was used 64 mice divided in 8 groups; respectively, 4 groups received 400, 600, 800 and 1000 mg/kg of ethanol extract of &lt;em&gt;J. curcas &lt;/em&gt;seed; and the rest intake Diclofenac, Diazepam, Caffeine and a control group not received any substance. The effects on inflammation was evaluated by Carrageenan-Induced paw oedema test and by Paw skin temperature. Neurological symptoms of toxicity were evaluated using the Irwin test. For the analysis of quantitative variables were used the following tests: one-way ANOVA, Tukey, Shapiro-Wilk and Pearson correlation; for qualitative variables Chi square was used. &lt;strong&gt;Results: &lt;/strong&gt;According to the paw oedema, it was showed a trend on an inflammatory effect of the seeds of &lt;em&gt;J. curcas&lt;/em&gt;; this activity was statistically significant in doses of 1000 mg/kg. Also, the skin temperature measurements outcomes reveal a positive dose response manner. Regard to neurological manifestations, Straub tail was founded in doses of 400 mg/kg. Stereotypies were founded in doses of 400, 600, 800 and 1000 mg/kg throughout the evaluation. &lt;strong&gt;Conclusion:&lt;/strong&gt; &lt;em&gt;J. curcas&lt;/em&gt; seeds were showed an inflammatory effect. In addition, effects on the nervous system were founded as stereotypes and Straub tail.&lt;/p&gt;
</style></abstract><issue><style face="normal" font="default" size="100%">4</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><section><style face="normal" font="default" size="100%">335</style></section><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Zambrano-Huailla Alexander&lt;sup&gt;1,2&lt;/sup&gt;, Zambrano-Huailla Rommel&lt;sup&gt;1,2&lt;/sup&gt;, Goicochea-Lugo Sergio&lt;sup&gt;1,2&lt;/sup&gt;, Zavala-Flores Ernesto&lt;sup&gt;1,2&lt;/sup&gt;, Garc&amp;iacute;a-Berrocal Jorge&lt;sup&gt;1&lt;/sup&gt;, Chau-Saravia Angel&lt;sup&gt;1&lt;/sup&gt;, Pante-Medina Carlos&lt;sup&gt;2&lt;/sup&gt;, Salazar-Granara Alberto&lt;sup&gt;1,2&lt;/sup&gt; &lt;/strong&gt;&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Centro de Investigaci&amp;oacute;n de Medicina Tradicional y Farmacolog&amp;iacute;a (CIMTFAR) de la Facultad de Medicina Humana de la Universidad de San Martin de Porres. (FMH-USMP), PERU. El Corregidor Avenue 1531, La Molina, Lima12, PERU.&lt;/p&gt;

&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Sociedad Cient&amp;iacute;fica de Estudiantes de Medicina de la Universidad San Martin de Porres (SOCIEM-USMP), PERU.&lt;/p&gt;
</style></auth-address></record><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Noemi D. Paguigan,</style></author><author><style face="normal" font="default" size="100%">Christine L. Chichioco-Hernandez,</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">15-Lipoxygenase inhibition of selected Philippine medicinal plants</style></title><secondary-title><style face="normal" font="default" size="100%">Pharmacognosy Journal</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">Asthma</style></keyword><keyword><style  face="normal" font="default" size="100%">Inflammation</style></keyword><keyword><style  face="normal" font="default" size="100%">Lipoxygenase</style></keyword><keyword><style  face="normal" font="default" size="100%">Medicinal plants</style></keyword><keyword><style  face="normal" font="default" size="100%">Plant extracts</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">18th Feb,2014</style></date></pub-dates></dates><volume><style face="normal" font="default" size="100%">6</style></volume><pages><style face="normal" font="default" size="100%">43-46</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;Several extracts from Philippine medicinal plants used for asthma and other inflammatory diseases were evaluated for their ability to inhibit the action of 15-lipoxygenase. The inhibitory activity was tested spectrophotometrically using quercetin as positive control. Eleven species belonging to 11 families displayed varying inhibitory activities. &lt;em&gt;Commelina diffusa&lt;/em&gt; and &lt;em&gt;Euphorbia hirta&lt;/em&gt; showed the highest inhibitory activity at 51.3% and 48.5%, respectively. These plants may contain new 15-lipoxygenase inhibitors.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Key words: &lt;/strong&gt;Asthma, inflammation, lipoxygenase, medicinal plants, plant extra.&lt;/p&gt;</style></abstract><issue><style face="normal" font="default" size="100%">1</style></issue><work-type><style face="normal" font="default" size="100%">Original Article</style></work-type><auth-address><style face="normal" font="default" size="100%">&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;strong&gt;Noemi D. Paguigan&lt;sup&gt;1&lt;/sup&gt; and Christine L. Chichioco-Hernandez&lt;sup&gt;*,2&lt;/sup&gt;&lt;/strong&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;1&lt;/sup&gt;Natural Sciences Research Institute, University of the Philippines, Diliman, Quezon City, Philippines 1101&lt;sup&gt;&lt;/sup&gt;&lt;/p&gt;&lt;p style=&quot;text-align: justify;&quot;&gt;&lt;sup&gt;2&lt;/sup&gt;Institute of Chemistry, College of Science, University of the Philippines, Diliman, Quezon City, Philippines 1101&lt;/p&gt;</style></auth-address></record></records></xml>